ZHIHF · Zhihu Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on ZHIHF. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Three Form 4 filings appeared within 14 days of investigation trigger, satisfying the filing-count threshold. However, upon detailed examination all three transactions were RSU grants (Derek Chen: 135,468 RSUs at $0.01) or RSU vestings (Hope Ni and Cheng Li-Lan: each vesting 33,867 shares at $0.01). These are equity compensation events — not open-market purchases under transaction code P. A fourth filing from April 17 shows CFO Wang Han's 330,000 share acquisition via performance-RSU vesting at $0.01. No genuine open-market insider purchases exist in any of the recent filings. The stock appears delisted or trading OTC with no price data available; fundamentals and options tools returned errors indicating illiquidity. ZHIHF is a Chinese VIE-structured company subject to material regulatory, geopolitical, and audit-risk factors.